Company Overview and News

 
Insider trading: Beware of your ‘likes’ on social media

2018-04-20 thehindubusinessline
KS Badri Narayanan Are you a stock trader or investor and active on social media such as Facebook, WhatsApp and Instagram?
Upvote Downvote

 
Weak rupee, TCS mood-upper lift Nifty IT index to new high

2018-04-20 thehindubusinessline
Our Bureau The Nifty IT index on Friday registered a lifetime high on weak rupee against the US dollar and a robust growth guidance by Tata Consultancy Services.
Upvote Downvote

 
IIFL Asset Management launches capital enhancer fund

2018-04-20 thehindubusinessline
Our Bureau The IIFL Asset Management has launched the IIFL Capital Enhancer Fund - Series 1, an annual interval scheme investing in equity and equity-related securities. The objective of this scheme which will be launched during the weekend is to achieve long-term capital appreciation by investing in equity and equity-related securities, with the strategy of hedging the portfolio with Nifty 50 Put Option and other equity derivatives.
Upvote Downvote

 
Mangalam Organics: Buyback offer opens

2018-04-20 thehindubusinessline
The buyback offer of Mangalam Organics will open on Monday and close on May 8. The company plans to mop up 6.10 lakh shares, representing 6.74 per cent of the paid-up equity share capital, from existing shareholders at ₹230 a share. The buyback offer is through the tender offer route and shareholders whose names appear on the book of Mangalam Organics as on the record date (April 4) are eligible to participate.
Upvote Downvote

 
Company News: Avanti Feeds

2018-04-20 thehindubusinessline
A meeting of the board of directors of Avanti Feeds will be held on May 9 to consider sub-division of the face value of its equity shares and issue of bonus shares. If the proposal is approved, the board will then seek approval from the shareholders of the company. Shares of Avanti Feeds jumped 7.72 per cent at ₹2,357.05 on the NSE.
Upvote Downvote

 
Unichem Labs: No observation from USFDA

2018-04-20 thehindubusinessline
Drug firm Unichem Laboratories on Friday said it has not received any observations from the US health regulator following completion of inspection of the company’s facility in Ghaziabad, Uttar Pradesh. The facility was inspected by the United States Food and Drug Administration from April 16 to April 20, Unichem Laboratories said, and added that this inspection also covered one of the ‘first to file’ molecules.
Upvote Downvote

 
Company News: Prakash Constrowell

2018-04-20 thehindubusinessline
Prakash Constrowell has been declared the L-1 bidder by the Municipal Corporation of Greater Mumbai for the new dumpsite reclamation at Mulund dumping ground through adoption of suitable technology for the existing garbage dump. The completion period is five years. The stock of Prakash Constrowell closed at ₹8, a gain of 9.59 per cent, on the NSE.
Upvote Downvote

 
Broker's call: NMDC

2018-04-20 thehindubusinessline
NMDC is engaged in mining of iron ore. The company’s segments include iron ore and other minerals & services. It is also engaged in the production and sale of diamond, sponge iron and wind power.
Upvote Downvote

 
Company News: Dynacons Systems

2018-04-20 thehindubusinessline
Dynacons Systems and Solutions has secured an order for an enterprise storage solution worth ₹10.91 crore from the National Payments Corporation of India (NPCI). The terms of the contract include supply, installation and commissioning of SAN storage; host integration & integration with switch; replication set-up & fail over for Chennai & Hyderabad; periodical firmware upgrade; and SLA-based support.
Upvote Downvote

 
Avanti Feeds Limited - Trading Window

2018-04-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Avanti Feeds Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Avanti Feeds Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Avanti Feeds Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...